Singapore, Sept. 7 -- elivity(R), Singapore's science-first longevity supplement brand, has introduced NANOBOOST in Asia. Co-developed with a German biotech spin-off of Hamburg University, NANOBOOST i... Read More
Singapore, Sept. 7 -- Building on an established relationship between the two institutions, South Korea-based International Vaccine Institute (IVI) and Karolinska Institutet (KI) have signed a Memoran... Read More
Singapore, Sept. 4 -- Scientists from Nanyang Technological University (NTU), Singapore have developed microscopic peptide droplets that deliver large amounts of gene silencing molecules into cancer a... Read More
Singapore, Sept. 4 -- Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and license agreement with a subsidiary of GSK plc, granting the GS... Read More
Singapore, Sept. 4 -- ENA Respiratory, a clinical-stage pharmaceutical startup developing host defence enhancers for the prevention of complications associated with respiratory viral infections in at-... Read More
Singapore, Sept. 4 -- KKR, a leading global investment firm, and Avisena Healthcare, a Malaysian healthcare provider, have announced that funds managed by KKR have entered into a definitive agreement ... Read More
Singapore, Sept. 4 -- There is a particular energy that settles over the Bangkok International Trade and Exhibition Centre (BITEC) in the first week of September, and this year it was unmistakable. Th... Read More
Singapore, Sept. 4 -- Singapore has spent decades building the foundations of a global biomedical hub. The more difficult task now is not to simply fund more science or attract more multinational inve... Read More
Singapore, Sept. 3 -- Students will have new opportunities to study across Melbourne and Indonesia with three dual degree programmes launched by the University of Melbourne and Universitas Gadjah Mada... Read More
Singapore, Sept. 3 -- Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule. Under the agreement, B... Read More